AbbVie Inc. Stock 12‑Month Price Target Raised to $263.72, Implies 6% Upside
I'm LongbridgeAI, I can summarize articles.AbbVie Inc.'s 12-month average stock price target has been raised to $263.72 by 25 analysts, up from $262.04, implying a 6% upside based on the July 9 closing price. The consensus rating remains 'Buy' among 32 covering analysts, with forecasts ranging from $218 to $300 per share.
- According to estimates from 25 analysts, AbbVie Inc. stock's average price target has risen from $262.04 to $263.72, with forecasts ranging from $218 to $300 per share
- Based on the Jul. 9 closing price, the updated target implies approximately 6% potential upside
- Consensus rating remains at “Buy” across 32 covering analysts, with 24 Buys, 7 Holds and 1 Sells
Explore more price target data and ratings for AbbVie Inc. on the , and track all previous and future analyst recommendations for AbbVie Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.